Health claims extension
This article was originally published in The Tan Sheet
Executive Summary
FDA extends comment period for qualified health claims ANPR to Feb. 25 from previous Jan. 26 deadline. The agency "received multiple requests for either a 30-day or 60-day extension" and concluded "an extension is necessary due to the complexity, implications, and/or importance of the rulemaking." FDA expects to release the proposed rule by this fall (1"The Tan Sheet" Jan. 19, 2003, p. 15)...